Europe Health Technology Assessment Associate Lead

Role Overview

This position involves a dynamic partnership with regional access leads to identify and fulfill evidence requirements from Health Technology Assessment (HTA) stakeholders throughout Europe. The successful candidate will collaborate closely with various internal cross-functional teams to consolidate and synthesize evidence for EU HTA-related initiatives, such as PICO surveys.

Key Responsibilities

• Assist in the formulation of market access strategies and clinical development plans, concentrating on the evidence needs specific to HTA and payer stakeholders in Europe and Canada.
• Co-lead the preparation and submission of documents for the European Union Health Technology Assessment, ensuring adherence to EU Joint HTA guidelines and procedures.
• Advocate for organizational values and promote collaboration within cross-functional teams to elevate awareness and understanding of EU HTA evidence requirements.
• Co-develop high-quality HTA submission dossiers for initiatives like Joint Clinical Assessments and Joint Scientific Consultations for new oncology therapies.
• Work alongside global and EUCAN PVA leads to map comprehensive HTA and payer evidence requirements, contributing essential inputs to global development plans.
• Represent evidence needs in internal forums as a key member of the Payer Value and Patient Access team, ensuring communication regarding changes in joint HTA guidelines.
• Collaborate with the EUCAN Access Lead to gather feedback on clinical trial considerations, enhancing clinical development and evidence strategies.
• Act as the primary point of contact for all Joint Clinical Assessment and Joint Scientific Consultation evidence topics related to priority assets.
• Guide internal stakeholders on methodological requirements relating to EU HTA regulations, supplementing product area expertise.
• Maintain current knowledge of EU HTA guidelines and processes, conveying pertinent updates to internal teams.
• Analyze trends and relationships among national HTA/payers and regulatory agencies to shape reimbursement and joint HTA strategies.

Qualifications and Skills

Required

• Bachelor’s degree; advanced degree preferred (MSc, PhD, MPH, MPP, MBA).
• At least 6 years of experience in the biopharmaceutical industry or healthcare consulting.
• A minimum of 4 years in market access, health economics, pricing, or outcomes research, with progressively increased responsibility.
• In-depth understanding of the EU payer and HTA landscape, including reimbursement methodologies.
• Exceptional communication skills, with demonstrated ability to influence and collaborate across teams.
• Proven experience managing complex projects under pressure.
• Solid comprehension of drug development processes and familiarity with cross-functional pharmaceutical teams.
• Adept at navigating ambiguity and complex trade-offs in discussions.
• Skilled at framing HTA strategies and translating evidence into clear value propositions for stakeholders.
• Hands-on experience with HTA tools and methods of evidence synthesis.

Preferred

• Advanced academic qualifications in health economics or related fields.
• Experience in oncology and above country roles.
• Previous engagement with national HTA submissions or scientific consultations is advantageous.

Travel Requirements

Willingness to travel domestically and/or internationally up to 20% is necessary.

Additional Information

• Demonstrated experience in assessing evidence needs for major HTA/payer stakeholders in EU5 and Canada.
• Proficiency in internal stakeholder management and solution-oriented thinking.
• A solid grasp of the clinical development process is crucial.